Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Szkandera, J; Absenger, G; Stotz, M; Weissmueller, M; Winder, T; Langsenlehner, T; Samonigg, H; Renner, W; Schippinger, W; Gerger, A.
The Functional Polymorphism of Erythropoietin Gene rs1617640 G>T Is Not Associated with Susceptibility and Clinical Outcome of Early-stage Breast Cancer.
Anticancer Res. 2012; 32(8):3473-3478
Web of Science
PubMed
- Führende Autor*innen der Med Uni Graz
-
Gerger Armin
-
Szkandera Joanna
- Co-Autor*innen der Med Uni Graz
-
Absenger Gudrun
-
Langsenlehner Tanja
-
Renner Wilfried
-
Samonigg Hellmut
-
Schippinger Walter
-
Stotz Michael
-
Weissmüller Melanie
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Abstract:
- Recent data suggest that erythropoietin (EPO) plays a substantial role in cancer development and clinical outcome by stimulating cell proliferation, invasion and angiogenesis. A functional polymorphism (rs1617640 G>T) in the promoter region of the EPO gene increases EPO protein expression. In the present study, we investigated the association of EPO rs1617640 G>T with susceptibility and clinical outcome of early-stage breast cancer. Genomic DNA of 539 female patients with histologically confirmed early-stage breast cancer and 804 controls was genotyped for EPO rs1617640 G>T. No association was found between EPO rs1617640 G>T and early-stage breast cancer susceptibility and clinical outcome (hazard ratio=1.24, 95% confidence interval=1.82-1.90, p=0.31). In conclusion, our findings suggest a lack of influence of EPO rs1617640 G>T on early-stage breast carcinogenesis and clinical outcome.
- Find related publications in this database (using NLM MeSH Indexing)
-
Breast Neoplasms - genetics Breast Neoplasms - pathology
-
Cell Transformation, Neoplastic - genetics Cell Transformation, Neoplastic - pathology
-
Erythropoietin - genetics
-
Female -
-
Genetic Predisposition to Disease -
-
Humans -
-
Polymorphism, Genetic -
-
Promoter Regions, Genetic -
-
Treatment Outcome -
- Find related publications in this database (Keywords)
-
Breast cancer
-
germline polymorphism
-
erythropoietin